NapaJen Pharma, Inc.
PrivateLast Round
Series C
Dec 25, 2018
Total Funding Raised
$33.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NapaJen Pharma, Inc. is a drug discovery company that develops oligonucleotide therapeutics for immune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NapaJen Pharma, Inc. Comparables
Compare NapaJen Pharma, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phio Pharmaceuticals Corp. | 73% | |
| MiNA Therapeutics | 70% | |
| Arrowhead Pharmaceuticals | 64% |
NapaJen Pharma, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Dec 25, 2018 | ||||
| Series B | Dec 7, 2016 | ||||
| Series A | Feb 3, 2014 |
NapaJen Pharma, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mitsui Global Investment | Series B, Series C, Series A |
| Mizuho Capital | Series B, Series A |
| Nissay Capital | Series B |
| INCJ, Ltd. | Series B, Series C, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 316% MoM, from 252 to 1K.
- Apr 17, 2026
Monthly visitors increased 400% MoM.
NapaJen Pharma, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NapaJen Pharma, Inc.'s valuation, stock price, and market status.
Is NapaJen Pharma, Inc. a public or private company?
NapaJen Pharma, Inc. is a private company.
What is the current stock price of NapaJen Pharma, Inc.?
NapaJen Pharma, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is NapaJen Pharma, Inc. worth (valuation)?
Valuation information for NapaJen Pharma, Inc. is not publicly available.
Can I buy NapaJen Pharma, Inc. stock?
NapaJen Pharma, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NapaJen Pharma, Inc.'s last funding round?
NapaJen Pharma, Inc.'s most recent funding round was Series C on December 25, 2018.
Who are the main investors in NapaJen Pharma, Inc.?
Key investors in NapaJen Pharma, Inc. include INCJ, Ltd..
Will NapaJen Pharma, Inc. IPO soon?
No public IPO plans have been announced for NapaJen Pharma, Inc..
How can I track NapaJen Pharma, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NapaJen Pharma, Inc.'s secondary market activity and sign up for updates.